1484:
1427:
1566:
377:
71:
347:"Notification of Approval to Manufacture and Market Nanozora® 30mg Syringes for S.C. Injection, a Therapy for Rheumatoid Arthritis, in Japan Japan's First NANOBODY® Therapeutic"
252:
1532:
1468:
370:
34:
1551:
1525:
1461:
363:
1386:
1561:
1556:
1518:
1454:
92:
1358:
1368:
276:) is a trivalent anti-tumour necrosis factor alpha (TNFα) nanobody designed for the treatment of inflammatory diseases.
149:
1403:
952:
1391:
464:
386:
668:
292:
1498:
1434:
113:
44:
27:
853:
812:
652:
444:
288:
346:
744:
414:
355:
328:
61:
1502:
1438:
122:
734:
724:
320:
194:
158:
1495:
1152:
928:
1491:
1397:
311:
Kratz F, Elsadek B (July 2012). "Clinical impact of serum proteins on drug delivery".
1545:
1307:
1108:
1053:
978:
938:
858:
752:
398:
390:
1297:
1282:
1262:
1252:
1231:
1147:
1088:
1073:
1043:
1023:
1018:
993:
973:
968:
913:
903:
893:
843:
838:
833:
762:
647:
631:
534:
524:
519:
494:
434:
324:
1363:
1353:
1292:
1277:
1267:
1257:
1236:
1221:
1206:
1201:
1196:
1171:
1124:
1103:
1098:
1093:
1083:
1078:
1063:
1038:
1028:
1008:
988:
983:
948:
943:
933:
923:
918:
888:
878:
848:
802:
797:
787:
772:
757:
729:
714:
699:
694:
689:
657:
600:
595:
585:
565:
544:
539:
509:
429:
1483:
1426:
1323:
1302:
1287:
1272:
1216:
1211:
1191:
1186:
1157:
1131:
1068:
1048:
1033:
1013:
1003:
958:
908:
898:
873:
868:
863:
828:
823:
792:
777:
719:
709:
704:
684:
621:
616:
605:
575:
570:
514:
489:
474:
459:
454:
424:
233:
133:
20:
1226:
1058:
883:
782:
767:
626:
590:
580:
554:
549:
529:
504:
499:
484:
479:
449:
419:
49:
332:
636:
559:
469:
439:
1113:
998:
1338:
284:
280:
349:(Press release). Taisho Pharmaceutical Holdings. September 26, 2022.
291:. In 2022, ozoralizumab was approved in Japan for the treatment of
178:
287:
NV. Ablynx has licensed the rights to the antibody in China to
169:
359:
1506:
1442:
259:
1346:
1336:
1316:
1245:
1179:
1170:
1139:
811:
743:
677:
406:
397:
232:
193:
188:
168:
148:
132:
112:
107:
91:
86:
70:
60:
55:
43:
33:
26:
121:
1567:Antineoplastic and immunomodulating drug stubs
1526:
1462:
371:
8:
19:
1533:
1519:
1469:
1455:
1343:
1176:
403:
378:
364:
356:
157:
303:
18:
7:
1480:
1478:
1423:
1421:
177:
1505:. You can help Knowledge (XXG) by
1441:. You can help Knowledge (XXG) by
14:
1482:
1425:
211:
205:
1552:Drugs not assigned an ATC code
279:Ozoralizumab was developed by
223:
217:
199:
1:
325:10.1016/j.jconrel.2011.11.028
1583:
1477:
1420:
189:Chemical and physical data
1562:Monoclonal antibody stubs
1557:Drugs developed by Pfizer
1381:
249:
283:Inc, and now belongs to
1437:–related article is a
465:Camidanlumab tesirine
387:Monoclonal antibodies
1140:Chimeric + humanized
669:Nivolumab/relatlimab
293:rheumatoid arthritis
1435:monoclonal antibody
28:Monoclonal antibody
23:
16:Monoclonal antibody
1408:Never to phase III
854:Certolizumab pegol
821:Immunosuppressive:
1514:
1513:
1450:
1449:
1418:
1417:
1377:
1376:
1332:
1331:
1166:
1165:
1121:Immune activation
613:Immune activation
415:Immunosuppression
313:J Control Release
267:
266:
1574:
1535:
1528:
1521:
1496:immunomodulatory
1486:
1479:
1471:
1464:
1457:
1429:
1422:
1344:
1177:
735:Zolimomab aritox
725:Telimomab aritox
404:
380:
373:
366:
357:
351:
350:
343:
337:
336:
308:
263:
262:
255:
244:
242:
225:
219:
213:
207:
201:
181:
161:
125:
24:
22:
1582:
1581:
1577:
1576:
1575:
1573:
1572:
1571:
1542:
1541:
1540:
1539:
1476:
1475:
1419:
1414:
1413:
1398:Clinical trials
1373:
1328:
1312:
1241:
1162:
1153:Rozanolixizumab
1141:
1135:
1127:
1116:
929:Lulizumab pegol
807:
739:
673:
393:
384:
354:
345:
344:
340:
310:
309:
305:
301:
258:
256:
253:(what is this?)
250:
240:
238:
228:
222:
216:
210:
204:
184:
164:
144:
128:
103:
82:
17:
12:
11:
5:
1580:
1578:
1570:
1569:
1564:
1559:
1554:
1544:
1543:
1538:
1537:
1530:
1523:
1515:
1512:
1511:
1492:antineoplastic
1487:
1474:
1473:
1466:
1459:
1451:
1448:
1447:
1430:
1416:
1415:
1412:
1411:
1410:
1409:
1406:
1395:
1389:
1383:
1382:
1379:
1378:
1375:
1374:
1372:
1371:
1366:
1361:
1356:
1350:
1348:
1341:
1334:
1333:
1330:
1329:
1327:
1326:
1320:
1318:
1314:
1313:
1311:
1310:
1305:
1300:
1295:
1290:
1285:
1280:
1275:
1270:
1265:
1260:
1255:
1249:
1247:
1243:
1242:
1240:
1239:
1234:
1229:
1224:
1219:
1214:
1209:
1204:
1199:
1194:
1189:
1183:
1181:
1174:
1168:
1167:
1164:
1163:
1161:
1160:
1155:
1150:
1144:
1142:
1137:
1136:
1118:
1117:
1111:
1106:
1101:
1096:
1091:
1086:
1081:
1076:
1071:
1066:
1061:
1056:
1051:
1046:
1041:
1036:
1031:
1026:
1021:
1016:
1011:
1006:
1001:
996:
991:
986:
981:
976:
971:
966:
961:
956:
953:+hyaluronidase
946:
941:
936:
931:
926:
921:
916:
911:
906:
901:
896:
891:
886:
881:
876:
871:
866:
861:
856:
851:
846:
841:
836:
831:
826:
817:
815:
809:
808:
806:
805:
800:
795:
790:
785:
780:
775:
770:
765:
760:
755:
749:
747:
741:
740:
738:
737:
732:
727:
722:
717:
712:
707:
702:
697:
692:
687:
681:
679:
675:
674:
672:
671:
661:
660:
655:
650:
640:
639:
634:
629:
624:
619:
609:
608:
603:
598:
593:
588:
583:
578:
573:
568:
563:
557:
552:
547:
542:
537:
532:
527:
522:
517:
512:
507:
502:
497:
492:
487:
482:
477:
472:
467:
462:
457:
452:
447:
442:
437:
432:
427:
422:
410:
408:
401:
395:
394:
385:
383:
382:
375:
368:
360:
353:
352:
338:
302:
300:
297:
265:
264:
247:
246:
236:
230:
229:
226:
220:
214:
208:
202:
197:
191:
190:
186:
185:
183:
182:
174:
172:
166:
165:
163:
162:
154:
152:
146:
145:
143:
142:
138:
136:
130:
129:
127:
126:
118:
116:
110:
109:
105:
104:
102:
101:
97:
95:
89:
88:
84:
83:
81:
80:
76:
74:
68:
67:
64:
58:
57:
53:
52:
47:
41:
40:
39:Whole antibody
37:
31:
30:
15:
13:
10:
9:
6:
4:
3:
2:
1579:
1568:
1565:
1563:
1560:
1558:
1555:
1553:
1550:
1549:
1547:
1536:
1531:
1529:
1524:
1522:
1517:
1516:
1510:
1508:
1504:
1501:article is a
1500:
1497:
1493:
1488:
1485:
1481:
1472:
1467:
1465:
1460:
1458:
1453:
1452:
1446:
1444:
1440:
1436:
1431:
1428:
1424:
1407:
1405:
1402:
1401:
1399:
1396:
1393:
1390:
1388:
1385:
1384:
1380:
1370:
1367:
1365:
1362:
1360:
1357:
1355:
1352:
1351:
1349:
1345:
1342:
1340:
1337:Inflammatory
1335:
1325:
1322:
1321:
1319:
1315:
1309:
1308:Tildrakizumab
1306:
1304:
1301:
1299:
1296:
1294:
1291:
1289:
1286:
1284:
1281:
1279:
1276:
1274:
1271:
1269:
1266:
1264:
1261:
1259:
1256:
1254:
1251:
1250:
1248:
1244:
1238:
1235:
1233:
1230:
1228:
1225:
1223:
1220:
1218:
1215:
1213:
1210:
1208:
1205:
1203:
1200:
1198:
1195:
1193:
1190:
1188:
1185:
1184:
1182:
1178:
1175:
1173:
1169:
1159:
1156:
1154:
1151:
1149:
1146:
1145:
1143:
1138:
1134:
1133:
1130:
1126:
1122:
1115:
1112:
1110:
1109:Vobarilizumab
1107:
1105:
1102:
1100:
1097:
1095:
1092:
1090:
1087:
1085:
1082:
1080:
1077:
1075:
1072:
1070:
1067:
1065:
1062:
1060:
1057:
1055:
1054:Spartalizumab
1052:
1050:
1047:
1045:
1042:
1040:
1037:
1035:
1032:
1030:
1027:
1025:
1022:
1020:
1017:
1015:
1012:
1010:
1007:
1005:
1002:
1000:
997:
995:
992:
990:
987:
985:
982:
980:
979:Pembrolizumab
977:
975:
972:
970:
967:
965:
962:
960:
957:
954:
950:
947:
945:
942:
940:
939:Mogamulizumab
937:
935:
932:
930:
927:
925:
922:
920:
917:
915:
912:
910:
907:
905:
902:
900:
897:
895:
892:
890:
887:
885:
882:
880:
877:
875:
872:
870:
867:
865:
862:
860:
859:Crizanlizumab
857:
855:
852:
850:
847:
845:
842:
840:
837:
835:
832:
830:
827:
825:
822:
819:
818:
816:
814:
810:
804:
801:
799:
796:
794:
791:
789:
786:
784:
781:
779:
776:
774:
771:
769:
766:
764:
761:
759:
756:
754:
753:Andecaliximab
751:
750:
748:
746:
742:
736:
733:
731:
728:
726:
723:
721:
718:
716:
713:
711:
708:
706:
703:
701:
698:
696:
693:
691:
688:
686:
683:
682:
680:
676:
670:
666:
663:
662:
659:
656:
654:
651:
649:
645:
642:
641:
638:
635:
633:
630:
628:
625:
623:
620:
618:
614:
611:
610:
607:
604:
602:
599:
597:
594:
592:
589:
587:
584:
582:
579:
577:
574:
572:
569:
567:
564:
561:
558:
556:
553:
551:
548:
546:
543:
541:
538:
536:
533:
531:
528:
526:
523:
521:
518:
516:
513:
511:
508:
506:
503:
501:
498:
496:
493:
491:
488:
486:
483:
481:
478:
476:
473:
471:
468:
466:
463:
461:
458:
456:
453:
451:
448:
446:
443:
441:
438:
436:
433:
431:
428:
426:
423:
421:
417:
416:
412:
411:
409:
405:
402:
400:
399:Immune system
396:
392:
391:immune system
388:
381:
376:
374:
369:
367:
362:
361:
358:
348:
342:
339:
334:
330:
326:
322:
319:(2): 429–45.
318:
314:
307:
304:
298:
296:
294:
290:
286:
282:
277:
275:
271:
261:
254:
248:
237:
235:
231:
198:
196:
192:
187:
180:
176:
175:
173:
171:
167:
160:
156:
155:
153:
151:
147:
140:
139:
137:
135:
131:
124:
120:
119:
117:
115:
111:
106:
99:
98:
96:
94:
90:
85:
78:
77:
75:
73:
69:
65:
63:
59:
56:Clinical data
54:
51:
48:
46:
42:
38:
36:
32:
29:
25:
1507:expanding it
1489:
1443:expanding it
1432:
1298:Risankizumab
1283:Lebrikizumab
1263:Clazakizumab
1253:Anrukinzumab
1232:Tralokinumab
1148:Otelixizumab
1128:
1120:
1119:
1089:Tregalizumab
1074:Tislelizumab
1044:Satralizumab
1024:Rontalizumab
1019:Retifanlimab
994:Plozalizumab
974:Pateclizumab
969:Pascolizumab
964:Ozoralizumab
963:
914:Lampalizumab
904:Inebilizumab
894:Fontolizumab
844:Camrelizumab
839:Benralizumab
834:Atezolizumab
820:
763:Clenoliximab
664:
648:Bertilimumab
643:
632:Tremelimumab
612:
535:Mavrilimumab
525:Lirentelimab
520:Lerdelimumab
495:Fresolimumab
435:Atorolimumab
413:
341:
316:
312:
306:
278:
273:
272:(trade name
270:Ozoralizumab
269:
268:
257:
251:
123:1167985-17-2
93:Legal status
87:Legal status
21:Ozoralizumab
1394:from market
1364:Lemalesomab
1359:Fanolesomab
1354:Besilesomab
1293:Perakizumab
1278:Mirikizumab
1268:Gevokizumab
1258:Bimekizumab
1237:Ustekinumab
1222:Secukinumab
1207:Fezakinumab
1202:Canakinumab
1197:Briakinumab
1172:Interleukin
1125:Dostarlimab
1104:Visilizumab
1099:Vedolizumab
1094:Vatelizumab
1084:Toralizumab
1079:Tocilizumab
1064:Teclistamab
1039:Samalizumab
1029:Rovelizumab
1009:Ravulizumab
989:Pidilizumab
984:Pexelizumab
949:Ocrelizumab
944:Natalizumab
934:Mepolizumab
924:Ligelizumab
919:Letolizumab
889:Etrolizumab
879:Epratuzumab
849:Cedelizumab
803:Vapaliximab
798:Teneliximab
788:Lumiliximab
773:Gomiliximab
758:Basiliximab
730:Vepalimomab
715:Nerelimomab
700:Gavilimomab
695:Faralimomab
690:Elsilimomab
665:Combination
658:Zanolimumab
653:Ontamalimab
601:Ulocuplumab
596:Tezepelumab
586:Sifalimumab
566:Pamrevlumab
545:Morolimumab
540:Metelimumab
510:Lanadelumab
445:Avdoralimab
430:Anifrolumab
289:Eddingpharm
245: g·mol
108:Identifiers
100:Rx in Japan
62:Trade names
1546:Categories
1324:Lokivetmab
1317:Veterinary
1303:Spesolimab
1288:Olokizumab
1273:Ixekizumab
1217:Guselkumab
1212:Fletikumab
1192:Brazikumab
1187:Bermekimab
1158:Sutimlimab
1132:Ibalizumab
1069:Teplizumab
1049:Siplizumab
1034:Ruplizumab
1014:Reslizumab
1004:Quilizumab
959:Omalizumab
909:Itolizumab
899:Frexalimab
874:Efalizumab
869:Eculizumab
864:Daclizumab
829:Aselizumab
824:Apolizumab
793:Priliximab
778:Infliximab
720:Odulimomab
710:Maslimomab
705:Inolimomab
685:Afelimomab
622:Durvalumab
617:Ipilimumab
606:Varlilumab
576:Relatlimab
571:Placulumab
515:Lenzilumab
490:Emapalumab
475:Cemiplimab
460:Brodalumab
455:Bleselumab
425:Adalimumab
299:References
234:Molar mass
159:05ZCK72TXZ
134:ChemSpider
114:CAS Number
1404:Phase III
1392:Withdrawn
1369:Sulesomab
1246:Humanized
1227:Sirukumab
1059:Talizumab
884:Erlizumab
813:Humanized
783:Keliximab
768:Galiximab
627:Nivolumab
591:Tabalumab
581:Sarilumab
555:Oleclumab
550:Namilumab
530:Lirilumab
505:Ianalumab
500:Golimumab
485:Eldelumab
480:Dupilumab
450:Belimumab
420:Abrilumab
50:Humanized
745:Chimeric
637:Urelumab
560:Oxelumab
470:Carlumab
440:Avelumab
389:for the
333:22155554
274:Nanozora
260:(verify)
72:ATC code
66:Nanozora
1339:lesions
1114:TGN1412
999:PRO 140
195:Formula
1387:WHO-EM
1129:Other:
331:
285:Ablynx
281:Pfizer
179:D09944
45:Source
1490:This
1433:This
1347:Mouse
1180:Human
678:Mouse
644:Other
407:Human
1503:stub
1499:drug
1439:stub
329:PMID
209:2608
203:1682
170:KEGG
150:UNII
141:none
79:none
35:Type
1494:or
321:doi
317:161
243:.85
241:434
221:538
215:472
1548::
1400::
1123::
667::
646::
615::
418::
327:.
315:.
295:.
239:38
227:12
1534:e
1527:t
1520:v
1509:.
1470:e
1463:t
1456:v
1445:.
955:)
951:(
562:§
379:e
372:t
365:v
335:.
323::
224:S
218:O
212:N
206:H
200:C
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.